You are here

Industry News

Advamed Smart Brief

July 19, 2018
Abbott is making big investments in production capacity for its FreeStyle Libre continuous glucose monitor, as it expects the -More
July 19, 2018
A round of financing has been closed by Viz.ai, generating $21 million in proceeds for expansion of the company's development -More
July 19, 2018
Additional growth capital has been secured by Seattle-based Bardy Diagnostics from its existing equity investors.  -More
July 19, 2018
A round of equity financing involving eight anonymous sources has pulled in $2 million for Louisville, Ky.-based Neuronetrix, -More
July 19, 2018
Corindus Vascular Robotics has promoted Douglas Teany from senior vice president of research and development and operations t -More
July 19, 2018
A 107-patient clinical study found use of Applied Medical's Alexis wound protector/retractor was associated with a 52% reduct -More
July 19, 2018
The Compass CT disposable pressure transducer and the Advance CS coronary sinus infusion catheter have been launched by Cook  -More
July 19, 2018
Draft guidance has been issued by the FDA that would revise guidance issued in 1998 on metal expandable biliary stents used f -More
July 19, 2018
Zavation has obtained 510(k) clearance from the FDA for its Normandy vertebral body replacement system, which is indicated fo -More
July 19, 2018
The FDA has granted Vallum 510(k) clearance for its nanotextured spinal interbody fusion device, called PEEKplus.  -More

Industry News

Stat News
If your health care is covered by Medicare, like more than 55 million of your fellow Americans, where you live partly determines what Medicare will pay for. The process for deciding what items and services are covered from region to region needs reform.
PR Newswire
SAN ANTONIO, TX., May 23, 2018 - CeloNova BioSciences, Inc. (CeloNova), a global medical device company that offers a family of innovative products based upon its proprietary Polyzene™-F nanocoating technology, today announced 1-year clinical trial results from the eCOBRA post-market study of the company's COBRA PzF™ NanoCoated Coronary Stent (NCS) System. The clinical trial results demonstrated 4.3% target lesion revascularization, 0.3% late stent thrombosis and 8.6% major adverse...
Helius Medical Technologies, Inc.
NEWTOWN, PA.,  April 11, 2018 - Helius Medical Technologies, Inc. (“Helius” or the “Company”) today announced the pricing of an underwritten public offering of 2,141,900 shares of its Class A common stock and warrants to purchase 2,141,900 shares of its Class A common stock at a public offering price of US$7.47 per share and accompanying warrant, before underwriting discounts and commissions.  The net proceeds to the Company from this offering, after deducting the underwriting discounts,...
PR Newswire
California-based Myoscience, Inc. announced today that it received 510k clearance from the US FDA for Smart Tip with Nerve Stim, the latest innovative tip for Myoscience’s iovera° platform technology. With the FDA clearance for Smart Tip with Nerve Stim, physicians will be able to stimulate a nerve in advance of delivering iovera° cold therapy to the treatment area, reducing patient treatment times. Additionally, the use of Smart Tip with Nerve Stim enables physicians using iovera° to access...
Media Planet
It sometimes strikes without warning. People of any age, race, ethnicity and gender are at risk. In fact, it is the leading killer of both men and women in America. It is heart disease, and each year it claims the lives of over 600,000 Americans, accounting for one-quarter of all deaths in the United States.